Shamim Ruff Reata Pharmaceuticals Inc (RETA) insider trading activity

Shamim Ruff is Director of REATA PHARMACEUTICALS INC. Currently has a direct ownership of 0 shares of RETA, which is worth approximately $0. The most recent transaction as insider was on Sep 26, 2023, when has been sold 7,359 shares (Class A Common Stock) at a price of $0.0 per share, resulting in proceeds of $0. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 0

0% 3M change

0% 12M change

Total Value Held $0

Shamim Ruff Transaction History

Date	Transaction	Value	Shares Traded	Shares Held
Sep 26 2023	SELL Sale (or disposition) back to the issuer	-	7,359 Reduced 100.0%	0 Class A Common Stock
Jul 28 2023	SELL Open market or private sale	$1,354,904 $164.53 p/Share	8,235 Reduced 52.81%	7,359 Class A Common Stock
Jul 28 2023	BUY Exercise of conversion of derivative security	$759,267 $92.2 p/Share	8,235 Added 34.56%	15,594 Class A Common Stock
Jun 07 2023	BUY Grant, award, or other acquisition	$199,950 $93.61 p/Share	2,136 Added 22.5%	7,359 Class A Common Stock
Mar 10 2023	SELL Open market or private sale	$480,610 $83.73 p/Share	5,740 Reduced 52.36%	5,223 Class A Common Stock
Mar 10 2023	BUY Exercise of conversion of derivative security	$185,287 $32.28 p/Share	5,740 Added 34.37%	10,963 Class A Common Stock
Jun 08 2022	BUY Grant, award, or other acquisition	$177,450 $34.76 p/Share	5,105 Added 49.43%	5,223 Class A Common Stock
Jan 03 2022	BUY Grant, award, or other acquisition	$3,224 $27.32 p/Share	118 Added 50.0%	118 Class A Common Stock

Shamim Ruff

Director

Plano, TX

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells RETA shares.

Notify only if

Value

Insider Trading

Get notified when an Reata Pharmaceuticals Inc insider buys or sells RETA shares.

Notify only if

Operation

Value

Type

News

Receive news related to REATA PHARMACEUTICALS INC

Track Activities on RETA

Account